With its share price nudging 52-week highs and the integration of recently acquired Aegerion Pharmaceuticals Inc. going well, Ireland's Amryt Pharma PLC is now finalizing plans to list on the NASDAQ stock exchange.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?